跳至主要内容
临床试验/JPRN-jRCTs031210314
JPRN-jRCTs031210314招募中未知

Biomarker development study of pain quantification in patients with chronic pain using AMPA receptor density as an index

Miyazaki Tomoyuki0 个研究点目标入组 60 人开始时间: 2021年9月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 65age old(—)
性别
All

入选标准

  • Patients that meet all of the following criteria 1) to 4).
  • 1) Patients having sustained pain that lasts for 3 months or longer
  • 2) Patients who meet any of each following (1) to (3) without any overlap with each other
  • (1) Patients having postoperative pain that was developed after surgery: Patients must meet the following (A) and (B)
  • (A) Pain that is observed around surgical sites and developed after surgery
  • (B) Pain that onset was within 3 months after surgery
  • (2) Patients having pain caused by psychosocial factors: Patients must meet each criterion (A) or (B) and also meet the conditions of (C) and (D).
  • (A) Pain that followed Neurotic symptoms (psychiatric symptoms) such as anxiety and depressive symptoms
  • (B) Those corresponding to F45.4 Persistent somatic symptom pain disorder in ICD-10 or Physical symptom pain is the main symptom in DSM-5
  • (C) Does not meet the following diagnostic criteria;
  • Psychiatric disorders other than anxiety and depressive symptoms (e.g. panic disorder, general anxiety, mood disorders, illness anxiety, conversion disorder, delusion disorder, dysmorphophobia, obsessive-compulsive disorder, schizophrenia)
  • * Patients who had anxiety and mood disorder in the past and recovered currently can be participated in this study.
  • (D) There are no organic factors that cause pain
  • (3) Patients having pain caused by fibromyalgia: Patients must meet each criterion (A) or (B) and also meet (C) at the same time
  • (A) Those corresponding to either ACR1990 or ACR2010
  • (B) Those corresponding to M79.7 fibromyalgia in ICD-10
  • (C) Pain that did not appear prior to neurotic symptoms (psychiatric symptoms) such as anxiety and depressive symptoms
  • 3) Patients whose ages are between 20 and 65 at the time of registration
  • 4) Patients whose written consent regarding participation in this study can be obtained

排除标准

  • 1) Implantation of metal substances and pacemakers
  • 2) head, neck and body size not suitable for MRI scanner
  • 3) A tattoo larger than one point (including tattoo and art makeup)
  • 4) Advanced claustrophobic
  • 5) A remarkable variant of brain structure (including congenital and traumatic)
  • 6) Patient with renal dysfunction (Serum creatinine 1.5 mg / dl or more)
  • 7) Patient with liver dysfunction (AST 150 IU / L or more ALT 150 IU / L or more)
  • 8) Combination of serious neurologic diseases (neurodegenerative diseases, cases of cerebral hemorrhage and cerebral infarction which are not slight in the image before this study participation)
  • 9) Sensitive to alcohol
  • 10) Participating in unapproved nuclear medicine clinical trials and clinical trials within 6 months prior to enrollment
  • 11) During pregnancy, nursing or wishing to be pregnant(For premenopausal women,blood hCG is measured by blood sampling and confirmed to be less than 6 mIU / ml)
  • 12) Patients who have difficulty communicating in Japanese
  • 13) Patients judged as inappropriate for study by the research investigator

研究者

发起方
Miyazaki Tomoyuki

相似试验